1. Home
  2. OHI vs EXAS Comparison

OHI vs EXAS Comparison

Compare OHI & EXAS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • OHI
  • EXAS
  • Stock Information
  • Founded
  • OHI 1992
  • EXAS 1995
  • Country
  • OHI United States
  • EXAS United States
  • Employees
  • OHI N/A
  • EXAS N/A
  • Industry
  • OHI Real Estate Investment Trusts
  • EXAS Medical Specialities
  • Sector
  • OHI Real Estate
  • EXAS Health Care
  • Exchange
  • OHI Nasdaq
  • EXAS Nasdaq
  • Market Cap
  • OHI 10.6B
  • EXAS 8.8B
  • IPO Year
  • OHI N/A
  • EXAS N/A
  • Fundamental
  • Price
  • OHI $38.47
  • EXAS $43.03
  • Analyst Decision
  • OHI Buy
  • EXAS Strong Buy
  • Analyst Count
  • OHI 9
  • EXAS 18
  • Target Price
  • OHI $41.00
  • EXAS $70.59
  • AVG Volume (30 Days)
  • OHI 2.4M
  • EXAS 2.0M
  • Earning Date
  • OHI 05-01-2025
  • EXAS 05-07-2025
  • Dividend Yield
  • OHI 7.04%
  • EXAS N/A
  • EPS Growth
  • OHI 55.44
  • EXAS N/A
  • EPS
  • OHI 1.55
  • EXAS N/A
  • Revenue
  • OHI $1,051,390,000.00
  • EXAS $2,758,867,000.00
  • Revenue This Year
  • OHI $11.38
  • EXAS $13.02
  • Revenue Next Year
  • OHI $5.38
  • EXAS $13.02
  • P/E Ratio
  • OHI $24.62
  • EXAS N/A
  • Revenue Growth
  • OHI 10.70
  • EXAS 10.37
  • 52 Week Low
  • OHI $29.66
  • EXAS $40.62
  • 52 Week High
  • OHI $44.42
  • EXAS $79.62
  • Technical
  • Relative Strength Index (RSI)
  • OHI 55.78
  • EXAS 36.15
  • Support Level
  • OHI $37.43
  • EXAS $44.00
  • Resistance Level
  • OHI $38.25
  • EXAS $47.23
  • Average True Range (ATR)
  • OHI 0.81
  • EXAS 1.57
  • MACD
  • OHI 0.05
  • EXAS 0.06
  • Stochastic Oscillator
  • OHI 79.23
  • EXAS 15.86

About OHI Omega Healthcare Investors Inc.

Omega Healthcare Investors Inc is a healthcare facility real estate investment trust that invests in the United States real estate markets. Omega's portfolio focuses on long-term healthcare facilities. Omega has one reportable segment consisting of investments in healthcare-related real estate properties located in the United States and the United Kingdom. Its core business is to provide financing and capital to the long-term healthcare industry with a particular focus on skilled nursing facilities (SNFs), assisted living facilities (ALFs), and to a lesser extent, independent living facilities (ILFs), rehabilitation and acute care facilities (specialty facilities) and medical office buildings (MOBs).

About EXAS Exact Sciences Corporation

Exact Sciences Corporation, headquartered in Madison, Wisconsin, provides cancer screening and diagnostic test products in the United States and internationally. Exact's Cologuard screening test, a noninvasive stool-based DNA test, is a pre-cancer screening test for colorectal cancer. The company also competes in the precision oncology market with Oncotype DX, a suite of tissue-based genomic tests for estimating recurrence risk and likelihood of benefit from chemotherapy for breast and colon cancer, and OncoExTra, a liquid-based comprehensive genomic profiling test. It is developing liquid biopsy tests for molecular residual disease, colorectal cancer screening, and multicancer screening, too.

Share on Social Networks: